Elsevier Bringing Together Thought Leaders and Experts for New International Conference in Bionic Engineering

By Elsevier, PRNE
Tuesday, December 14, 2010

AMSTERDAM, December 15, 2010 - The International Bionic Engineering Conference 2011 (
www.bionicengineeringconference.com/index.html) organised by Elsevier,
the leading publisher of scientific, technical and medical information
products and services, aims to bridge the gap between academic research and
industrial development in a field that is rapidly growing and gaining
recognition across many disciplines.

Intended as a common ground for the exchange of ideas, Elsevier is
calling upon key researchers in industry and academia from around the globe
to engage each other with presentation and in conversation that inspires
bionic solutions to some of the major engineering problems facing industry
today. Topics include (but are not limited to): understanding of materials in
biomimetics; environmental aspects of biomimetics; sensors and signal
processing; bio-inspired materials and self-x-mechanisms; impact on
engineering; sustainability and responsibility; robotics, motion systems and
artificial intelligence; medicine (prosthetics and orthotics).

Dr. Angela Welch, Elsevier Publisher commented, "We're excited by this
opportunity to build on the successes of the previous Bionic Engineering
conferences organized by the Key Laboratory for Terrain-Machine Bionic
Engineering (China), and bring this unique event to a new geographic region
supporting advances in biologically-inspired solutions to a wide range of
real world challenges."

Professor Julian Vincent, the Conference Chairman and Professor of
Biomimetics at the University of Bath added, "Bionic Engineering is a growing
field. I believe it's very important to nurture this growth by holding
meetings like this one. It will serve as an excellent platform for scientists
to showcase their newest findings and interact directly with peers and
leaders in the field."

This newest International Bionic Engineering conference is held in
collaboration with the Journal of Bionic Engineering
(www.elsevier.com/wps/find/journaldescription.cws_home/707667/
description#description) and set to take place from 18th to 20th September,
2011
at Boston's Westin Boston Waterfront Hotel. Further information can be
found at www.bionicengineeringconference.com.

(Due to the length of this URL, it may be necessary to copy and paste
this hyperlink into your Internet browser's URL address field. Remove the
space if one exists.)

About Elsevier

Elsevier is a world-leading publisher of scientific, technical and
medical information products and services. The company works in partnership
with the global science and health communities to publish more than 2,000
journals, including The Lancet (www.thelancet.com/) and Cell (
www.cell.com/), and close to 20,000 book titles, including major
reference works from Mosby and Saunders. Elsevier's online solutions include
SciVerse ScienceDirect (www.sciencedirect.com/), SciVerse Scopus
(www.scopus.com/), Reaxys (www.reaxys.com/), MD Consult
(www.mdconsult.com/) and Nursing Consult (
www.nursingconsult.com/), which enhance the productivity of science
and health professionals, and the SciVal suite (www.scival.com/) and
MEDai's Pinpoint Review (www.medai.com/), which help research and
health care institutions deliver better outcomes more cost-effectively.

A global business headquartered in Amsterdam, Elsevier (
www.elsevier.com/) employs 7,000 people worldwide. The company is part
of Reed Elsevier Group PLC (www.reedelsevier.com/), a world-leading
publisher and information provider, which is jointly owned by Reed Elsevier
PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam),
REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).

    Media Contact
    Darren Sugrue
    +31(0)20-485-3506
    d.sugrue@elsevier.com

Media Contact: Darren Sugrue, +31(0)20-485-3506, d.sugrue at elsevier.com

YOUR VIEW POINT
NAME : (REQUIRED)
MAIL : (REQUIRED)
will not be displayed
WEBSITE : (OPTIONAL)
YOUR
COMMENT :